These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3113475)
1. Treatment with oral piperazine oestrone sulphate for genuine stress incontinence in postmenopausal women. Wilson PD; Faragher B; Butler B; Bu'Lock D; Robinson EL; Brown AD Br J Obstet Gynaecol; 1987 Jun; 94(6):568-74. PubMed ID: 3113475 [TBL] [Abstract][Full Text] [Related]
2. Estrogens and phenylpropanolamine in combination for stress urinary incontinence in postmenopausal women. Kinn AC; Lindskog M Urology; 1988 Sep; 32(3):273-80. PubMed ID: 3046105 [TBL] [Abstract][Full Text] [Related]
3. A double-blind cross-over study of piperazine oestrone sulphate and placebo with coagulation studies. Poller L; Thomson JM; Coope J Br J Obstet Gynaecol; 1980 Aug; 87(8):718-25. PubMed ID: 7000169 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of the therapeutic effectiveness of ethinyl oestradiol and oestrone sulphate on prolonged bleeding in women using depot medroxyprogesterone acetate for contraception. World Health Organization, Special Programme of Research, Development and Research Training in Human Reproduction, Task Force on Long-acting Systemic Agents for Fertility Regulation. Said S; Sadek W; Rocca M; Koetsawang S; Kirwat O; Piya-Anant M; Dusitsin N; Sethavanich S; Affandi B; Hadisaputra W; Kazi A; Ramos RM; d'Arcangues C; Belsey EM; Noonan E; Olayinka I; Pinol A Hum Reprod; 1996 Oct; 11 Suppl 2():1-13. PubMed ID: 8982739 [TBL] [Abstract][Full Text] [Related]
5. The use of intravaginal oestrogen cream in genuine stress incontinence. Hilton P; Stanton SL Br J Obstet Gynaecol; 1983 Oct; 90(10):940-4. PubMed ID: 6313035 [TBL] [Abstract][Full Text] [Related]
6. An evaluation of clinical response to piperazine oestrone sulphate ('Harmogen') in menopause patients. Aylward M; Holly F; Parker RJ Curr Med Res Opin; 1974; 2(7):417-23. PubMed ID: 4375554 [No Abstract] [Full Text] [Related]
7. The effect of oestrogen supplementation on post-menopausal urinary stress incontinence: a double-blind placebo-controlled trial. Jackson S; Shepherd A; Brookes S; Abrams P Br J Obstet Gynaecol; 1999 Jul; 106(7):711-8. PubMed ID: 10428529 [TBL] [Abstract][Full Text] [Related]
8. [Ultrasound imaging of the lower urinary tract in post-menopausal women with urinary stress or combined type of incontinence before and after intravaginal administration of estriol]. Martan A; Masata J; Halaska M; Voigt R Ceska Gynekol; 1999 Jan; 64(1):6-9. PubMed ID: 10377583 [TBL] [Abstract][Full Text] [Related]
9. Relationship between urinary profile of the endogenous steroids and postmenopausal women with stress urinary incontinence. Bai SW; Jung BH; Chung BC; Kim SU; Kim JY; Rha KH; Cho JS; Park YW; Park KH Neurourol Urodyn; 2003; 22(3):198-205. PubMed ID: 12707870 [TBL] [Abstract][Full Text] [Related]
10. Oestrone sulphate in plasma from postmenopausal women and the effects of oestrogen and androgen therapy. Towobola OA; Crilly RC; Oakey RE Clin Endocrinol (Oxf); 1980 Nov; 13(5):461-71. PubMed ID: 6261992 [TBL] [Abstract][Full Text] [Related]
11. Effect of oestrogen replacement therapy on blood coagulation factors in postmenopausal women. Varma TR Int J Gynaecol Obstet; 1983 Aug; 21(4):291-6. PubMed ID: 6141083 [TBL] [Abstract][Full Text] [Related]
12. Phenylpropanolamine in treatment of female stress urinary incontinence. Double-blind placebo controlled study in 24 patients. Collste L; Lindskog M Urology; 1987 Oct; 30(4):398-403. PubMed ID: 3310369 [TBL] [Abstract][Full Text] [Related]
13. Plasma levels of oestrone, oestradiol and gonadotrophins in postmenopausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin). Englund DE; Johansson ED Br J Obstet Gynaecol; 1978 Dec; 85(12):957-64. PubMed ID: 216384 [TBL] [Abstract][Full Text] [Related]
14. Estrogen effects on the urethra: beneficial effects in women with genuine stress incontinence. Elia G; Bergman A Obstet Gynecol Surv; 1993 Jul; 48(7):509-17. PubMed ID: 8355926 [TBL] [Abstract][Full Text] [Related]
15. The effect of oestradiol on vaginal collagen metabolism in postmenopausal women with genuine stress incontinence. Jackson S; James M; Abrams P BJOG; 2002 Mar; 109(3):339-44. PubMed ID: 11950190 [TBL] [Abstract][Full Text] [Related]
16. An objective assessment of physiotherapy for female genuine stress incontinence. Wilson PD; Al Samarrai T; Deakin M; Kolbe E; Brown AD Br J Obstet Gynaecol; 1987 Jun; 94(6):575-82. PubMed ID: 3497667 [TBL] [Abstract][Full Text] [Related]
17. Stress incontinence in females: treatment with phenylpropanolamine. A urodynamic and pharmacological evaluation. Fossberg E; Beisland HO; Lundgren RA Urol Int; 1983; 38(5):293-9. PubMed ID: 6685364 [TBL] [Abstract][Full Text] [Related]
18. [Is there a correlation between the degree of proliferation of vaginal and urethral epithelium and the incidence of stress incontinence? A contribution to estrogen therapy in stress incontinence]. Schwenzer T; Buth C; Degen W; Jahn K Geburtshilfe Frauenheilkd; 1987 Mar; 47(3):158-64. PubMed ID: 3582922 [TBL] [Abstract][Full Text] [Related]
19. Conservative treatment of urinary incontinence in women with special reference to the use of oestrogens. Punnonen R; Kilkku P; Kiukko P; Rauramo L Maturitas; 1981 Dec; 3(3-4):309-13. PubMed ID: 6278267 [TBL] [Abstract][Full Text] [Related]
20. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol. Sipinen S Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]